134 related articles for article (PubMed ID: 8392885)
41. Donor T-lymphocyte infusion for unrelated allogeneic bone marrow transplantation with CD3+ T-cell-depleted graft.
Lee CK; deMagalhaes-Silverman M; Hohl RJ; Hayashi M; Buatti J; Wen BC; Schlueter A; Strauss RG; Gingrich RD
Bone Marrow Transplant; 2003 Jan; 31(2):121-8. PubMed ID: 12621494
[TBL] [Abstract][Full Text] [Related]
42. Hematopoietic growth factors after HLA-identical allogeneic bone marrow transplantation in patients treated with methotrexate-containing graft-vs.-host disease prophylaxis.
Martin-Algarra S; Bishop MR; Tarantolo S; Cowles MK; Reed E; Anderson JR; Vose JM; Bierman P; Armitage JO; Kessinger A
Exp Hematol; 1995 Dec; 23(14):1503-8. PubMed ID: 8542938
[TBL] [Abstract][Full Text] [Related]
43. Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Ringdén O; Labopin M; Gorin NC; Le Blanc K; Rocha V; Gluckman E; Reiffers J; Arcese W; Vossen JM; Jouet JP; Cordonnier C; Frassoni F
J Clin Oncol; 2004 Feb; 22(3):416-23. PubMed ID: 14691124
[TBL] [Abstract][Full Text] [Related]
44. A comparison of related donor peripheral blood and bone marrow transplants: importance of late-onset chronic graft-versus-host disease and infections.
Anderson D; DeFor T; Burns L; McGlave P; Miller J; Wagner J; Weisdorf D
Biol Blood Marrow Transplant; 2003 Jan; 9(1):52-9. PubMed ID: 12533742
[TBL] [Abstract][Full Text] [Related]
45. Impact of cyclosporine and methylprednisolone dose used for prophylaxis and therapy of graft-versus-host disease on survival and relapse after allogeneic bone marrow transplantation.
Michallet M; Perrin MC; Belhabri A; Molina L; Nicolini F; Tigaud JD; Sotto JJ; Guyotat D; Fière D; Archimbaud E
Bone Marrow Transplant; 1999 Jan; 23(2):145-50. PubMed ID: 10197799
[TBL] [Abstract][Full Text] [Related]
46. Allogeneic and autologous bone marrow transplantation after consolidation therapy in high-risk acute myeloid leukemia in children. Towards a risk-oriented therapy.
Ortega JJ; Díaz de Heredia C; Olivé T; Bastida P; Llort A; Armadans L; Torrabadella M; Massuet L
Haematologica; 2003 Mar; 88(3):290-9. PubMed ID: 12651268
[TBL] [Abstract][Full Text] [Related]
47. Multicenter prospective study of interferon-alpha and conventional chemotherapy versus bone marrow transplantation for newly diagnosed patients with chronic myelogenous leukemia. Kouseisho Leukemia Study Group.
Ohnishi K; Minami S; Ueda T; Nishimura M; Tsubaki K; Takemoto Y; Takeshita A; Sao H; Kageyama S; Ueda R; Ohno R
Int J Hematol; 2000 Aug; 72(2):229-36. PubMed ID: 11039674
[TBL] [Abstract][Full Text] [Related]
48. Interstitial pneumonitis following allogeneic bone marrow transplantation in the treatment of leukemia based on BMT survey in Japan.
Inoue T; Masaoka T; Shibata H
Strahlenther Onkol; 1988 Dec; 164(12):729-33. PubMed ID: 3061043
[TBL] [Abstract][Full Text] [Related]
49. The impact of partial T cell depletion on overall transplant-related toxicity, graft function and survival after HLA-identical allogeneic bone marrow transplantation in standard risk adult patients with leukemia.
Schots R; Van Riet I; Ben Othman T; Trullemans F; De Waele M; Van Camp B
Bone Marrow Transplant; 2001 Nov; 28(10):917-22. PubMed ID: 11753544
[TBL] [Abstract][Full Text] [Related]
50. Interstitial pneumonitis in allogeneic bone marrow transplantation: a report from the Japanese BMT Study Group.
Teshima H; Masaoka T; Inoue T; Kato S; Naito K; Mori T; Kanamaru A; Saito Y; Ohira M; Moriyama Y
Bone Marrow Transplant; 1986 Dec; 1(2):179-83. PubMed ID: 2458786
[TBL] [Abstract][Full Text] [Related]
51. Risk factors for cytomegalovirus infection in BMT recipients transfused exclusively with seronegative blood products.
Rubie H; Attal M; Campardou AM; Gayet-Mengelle C; Payen C; Sanguignol F; Calot JP; Charlet JP; Robert A; Huguet F
Bone Marrow Transplant; 1993 Mar; 11(3):209-14. PubMed ID: 8385522
[TBL] [Abstract][Full Text] [Related]
52. Some but not all benefits of intravenous immunoglobulin therapy after marrow transplantation appear to correlate with IgG trough levels.
Cottler-Fox M; Lynch M; Pickle LW; Cahill R; Spitzer TR; Deeg HJ
Bone Marrow Transplant; 1991 Jul; 8(1):27-33. PubMed ID: 1655138
[TBL] [Abstract][Full Text] [Related]
53. Salivary and serum immunoglobulins in recipients of transplanted allogeneic and autologous bone marrow.
Norhagen G; Engström PE; Björkstrand B; Hammarström L; Smith CI; Ringdén O
Bone Marrow Transplant; 1994 Aug; 14(2):229-34. PubMed ID: 7994237
[TBL] [Abstract][Full Text] [Related]
54. Pulmonary function changes 100 days and one year after bone marrow transplantation.
Badier M; Guillot C; Delpierre S; Vanuxem P; Blaise D; Maraninchi D
Bone Marrow Transplant; 1993 Nov; 12(5):457-61. PubMed ID: 8298556
[TBL] [Abstract][Full Text] [Related]
55. Lethal complications in 30 patients after allogeneic BMT (BMT) and autografted (ABMT) patients (1980-1986) examined by autopsy.
Friedrich T; Püschel W; Helbig W; Kubel M; Hoffmann FA; Schwenke H; Pönisch W
Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):585-9. PubMed ID: 2480313
[TBL] [Abstract][Full Text] [Related]
56. Bone marrow transplantation in the People's Republic of China. Chinese Bone Marrow Transplant Registry.
Lu DP
Bone Marrow Transplant; 1994 Jun; 13(6):703-4. PubMed ID: 7920297
[TBL] [Abstract][Full Text] [Related]
57. Intravenous hyperimmune globulin prophylaxis against cytomegalovirus interstitial pneumonitis after allogenic bone marrow transplantation.
Jacobsen N; Schäfer U; Ostendorf P; Kubaneck B; Wolf H
Tokai J Exp Clin Med; 1985 Jun; 10(2-3):193-5. PubMed ID: 3010510
[TBL] [Abstract][Full Text] [Related]
58. Risk factors for cytomegalovirus pneumonia following allogeneic bone marrow transplantation after prophylaxis with intravenous immunoglobulin.
Krischer J; Elfenbein G; Babington R; Hong R; Jansen J; Lazarus H; Winton E; Rand K
Semin Hematol; 1992 Jul; 29(3 Suppl 2):89-95. PubMed ID: 1324530
[No Abstract] [Full Text] [Related]
59. Late-onset interstitial pneumonia following allogeneic bone marrow transplantation.
Wingard JR; Santos GW; Saral R
Transplantation; 1985 Jan; 39(1):21-3. PubMed ID: 2981443
[TBL] [Abstract][Full Text] [Related]
60. Variables predicting deep fungal infections in bone marrow transplant recipients.
Tollemar J; Ringdén O; Boström L; Nilsson B; Sundberg B
Bone Marrow Transplant; 1989 Nov; 4(6):635-41. PubMed ID: 2555004
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
